● Recruiting

DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)

Condition: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma · Sponsor: Dizal Pharmaceuticals

PhasePhase 2

Planned participants155

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This study will treat patients with CLL/SLL whose disease comes back or is not responding to prior therapy, or if they can not bear side effects of the prior treatment. This study will assess the anti-tumor activity of DZD8586 as monotherapy. It will help to understand what type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body.

This description comes directly from the study's public registry record.

Talk to the study team

Tianmo Sun · 0086-21-61097800 · Tianmo.Sun@dizalpharma.com

Always discuss trial participation with your own doctor first.

Locations (17)

Research Site	Hefei, Anhui, China	Recruiting
Research Site	Beijing, Beijing Municipality, China	Recruiting
Research Site	Beijing, Beijing Municipality, China	Recruiting
Research Site	Guangzhou, Guandong, China	Recruiting
Research Site	Guangzhou, Guandong, China	Recruiting
Research Site	Zhengzhou, Henan, China	Recruiting
Research Site	Wuhan, Hubei, China	Recruiting
First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital	Nanjing, Jiangsu, China	Recruiting
Research Site	Changchun, Jilin, China	Recruiting
Research Site	Dalian, Liaoning, China	Not Yet Recruiting
Research Site	Shenyang, Liaoning, China	Recruiting
Research Site	Jinan, Shandong, China	Recruiting

+ 5 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06539182